<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Orthop Case Reports</journal-id>
<journal-title>Journal of Orthopaedic Case Reports</journal-title>
<issn pub-type="ppub">2250-0685</issn>
<issn pub-type="epub">2321-3817</issn>
<publisher>
<publisher-name>Indian Orthopaedic Research Group</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">JOCR-12-35</article-id>
<article-id pub-id-type="doi">10.13107/jocr.2022.v12.i05.2806</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Primary Osseous Low-grade Myxofibrosarcoma of Metatarsal Masquerading as Enchondroma: A Case Report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Desai</surname>
<given-names>Sanjay</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choudhury</surname>
<given-names>Jayeta</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Varghese</surname>
<given-names>Kevin</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kapoor</surname>
<given-names>Tushar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Radiodiagnosis, Deenanath Mangeshkar Hospital, Eradhwane, Pune, Maharashtra, India</aff>
<author-notes>
<corresp id="cor1">
<bold>Address of Correspondence:</bold> Dr. Sanjay Desai, Consultant Musculoskeletal Radiologist, Deenanath Mangeshkar Hospital, Eradhwane, Pune - 411 004, Maharashtra, India. <bold>E-mail:</bold> <email xlink:href="drsanjaydesai@gmail.com">drsanjaydesai@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<month>05</month>
<year>2022</year>
</pub-date>
<volume>12</volume>
<issue>5</issue>
<fpage>35</fpage>
<lpage>39</lpage>
<history>
<date date-type="received"><day>09</day><month>10</month><year>2021</year></date>
<date date-type="rev-recd"><day>13</day><month>12</month><year>2021</year></date>
<date date-type="accepted"><month>03</month><year>2022</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Indian Orthopaedic Research Group</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<sec id="st1">
<title>Introduction:</title>
<p>Low-grade myxofibrosarcoma (LGMFS) is a neoplasm of soft tissues. According to the World Health Organization, LGMFS is a malignant myofibroblastic tumor arising from deep soft tissues with potential for recurrence and late metastatic spread. The incidence estimates are 0.18/million, accounting for 0.6&#x0025; of all soft-tissue sarcomas. It can directly invade the bone and metastasize to bone; however, primary osseous low-grade myxofibrosarcoma is a rare entity. Thus, recognizing atypical presentations of uncommon neoplasms are a pertinent skill for the radiologist due to significant implications for management.</p>
</sec>
<sec id="st2">
<title>Case Report:</title>
<p>A 40-year-old male with complaints of midfoot pain was referred to radiology department for imaging. Radiographs of the foot showed a lytic mildly expansile lesion in the first metacarpal with wide zone of transition and no sclerotic margin or matrix calcification. Magnetic resource imaging (MRI) and computed tomography (CT) examination demonstrated well defined lobulated lesion which appeared heterogeneously hyperintense on T2W images with cortical breach, extraosseous soft-tissue component, and early rapid progressive enhancement. The radiological diagnosis of enchondroma with pathological fracture was considered. Atypical findings of early progressive enhancement and extraosseous soft-tissue component were, however, incongruous with enchondroma and possibility of an aggressive/malignant etiology was also considered. Hence, the lesion was biopsied and diagnosis of LGMFS was made and subsequently confirmed on excised specimen. Follow-up CT scan post 6 months of surgical resection demonstrated no recurrence.</p>
</sec>
<sec id="st3">
<title>Conclusion:</title>
<p>Primary osseous LGMFS is a rare entity and radiologically mimics enchondromas. Both LGMFS and enchondromas show T2W hyperintensity. MRI features that distinguish LGMFS from enchondroma include low apparent diffusion coefficient values and slow progressive enhancement in dynamic contrast-enhanced MRI.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Apparent diffusion coefficient</kwd>
<kwd>computed tomography</kwd>
<kwd>enchondroma</kwd>
<kwd>magnetic resource imaging</kwd>
<kwd>myxofibrosarcoma</kwd>
<kwd>radiograph</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<boxed-text>
<title>Learning Point of the Article:</title>
<p>Primary intraosseous low-grade myxofibrosarcomas radiologically mimic enchondromas and the MRI features that distinguish the former from the latter include low ADC values and slow progressive contrast enhancement.</p>
</boxed-text>
<sec id="sec1-1" sec-type="intro">
<title>Introduction</title>
<p>Low-grade myxofibrosarcoma (LGMFS) according to the World Health Organization is a malignant fibroblastic/myofibroblastic tumor arising from deep soft tissues with potential for recurrence and late metastatic spread [<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>]. The incidence estimates are 0.18/million, accounting for 0.6&#x0025; of all soft-tissue sarcomas [<xref ref-type="bibr" rid="ref3">3</xref>]. Primary osseous myxofibrosarcoma is a rare pathology of bones especially in metatarsals which radiologically mimics enchondroma [<xref ref-type="bibr" rid="ref4">4</xref>]. We have limited understanding of its presentation and course owing to sporadic reports in the literature. These are low-grade malignancies and show low risk of metastasis with high potential for local recurrence [<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>]. With every recurrence, they are associated with increased risk of metastasis. Hence, they need to be differentiated from enchondromas by magnetic resource imaging (MRI) evaluation. Recognizing atypical presentations of uncommon neoplasms are a pertinent skill for the Musculoskeletal Radiologist, due to significant implications for management. We highlight the need to maintain an index of suspicion especially in the setting of discordant findings. Unclear diagnosis must be diligently followed up.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>Case Report</title>
<p>A 40-year-old male, otherwise well, presented with recent onset pain in midfoot region. Physical examination revealed non-palpable mass. No constitutional symptoms of fever or weight loss were present. Hemoglobin was 15 g &#x0025;, red blood cells 5.15 &#x00D7; 1012/L, total blood count was 9000 &#x00D7; 109/L, and erythrocyte sedimentation rate 10 mm/h. Patient was referred to radiology department for imaging. Radiographs of the foot showed a lytic expansile lesion in first metacarpal with wide zone of transition, no sclerotic margin, and no matrix calcification (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Subsequently, the patient was referred for a MRI examination with computed tomography (CT) correlation to further characterize the lesion. The lesion was well defined, lobulated with endosteal scalloping. It was heterogeneously hyperintense on T2W images, hypointense on T1W images, with slow progressive peripheral nodular enhancement in dynamic contrast-enhanced MRI (DCEMRI) curves, and area of cortical breach with extraosseous soft-tissue component (<xref ref-type="fig" rid="F2">Fig. 2a</xref>, <xref ref-type="fig" rid="F2">b</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>). Few areas of diffusion restriction were noted within the lesion (<xref ref-type="fig" rid="F5">Fig. 5</xref>).</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Anterior posterior radiograph of foot shows a lytic mildly expansile lesion (red arrow) in first metacarpal with wide zone of transition and no sclerotic margin.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>(a and b) Sagittal T2FS and sagittal T1 images reveal a fluid intensity mildly expansile intramedullary lesion (red arrows) causing cortical scalloping.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g002.tif"/>
</fig>
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Axial post-contrast image shows heterogeneous enhancement in the intramedullary lesion (red arrow). Mild extraosseous soft-tissue is seen.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g003.tif"/>
</fig>
<fig id="F4">
<label>Figure 4</label>
<caption>
<p>Dynamic curves-red curve which demonstrates slow progressive uptake is suggestive of neoplastic lesion. Region of interest red curve: Neoplastic lesion. Green curve: Muscle. Yellow curve: Within the vessel.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g004.tif"/>
</fig>
<fig id="F5">
<label>Figure 5</label>
<caption>
<p>Cor diffusion-weighted imaging and apparent diffusion coefficient shows few areas of restricted diffusion in the periphery of the lesion (red arrows).</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g005.tif"/>
</fig>
<p>In view of above findings, the radiological diagnosis of enchondroma with a pathological fracture was made. However, due to atypical presentation of the lesion (heterogeneous hyperintensity on T2W images, early progressive peripheral nodular enhancement, extraosseous soft-tissue component, and areas of diffusion restriction), a possibility of aggressive/malignant etiology was also considered and, hence, a biopsy was performed.</p>
<p>The biopsy demonstrated a hypocellular tumor composed of short spindle and stellate shaped tumor cells embedded on a markedly myxoid stroma without any chondroblasts or osteoclastic giant cells on HPE (<xref ref-type="fig" rid="F6">Fig. 6a</xref> and <xref ref-type="fig" rid="F6">b</xref>). Diagnosis of LGMFS was made. Immunohistochemistry was positive for smooth muscle antigen, vimentin and negative for synaptophysin-100, cluster of differentiation 34, desmin (<xref ref-type="fig" rid="F7">Fig. 7a</xref> and <xref ref-type="fig" rid="F7">b</xref>). MiB-1 labeling index was focally high (10&#x2013;25&#x0025;).</p>
<fig id="F6">
<label>Figure 6</label>
<caption>
<p>(a and b) HPE shows hypocellular tumor composed of short spindle and stellate shaped tumor cells embedded on a markedly myxoid stroma without any chondroblasts or osteoclastic giant cells.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g006.tif"/>
</fig>
<fig id="F7">
<label>Figure 7</label>
<caption>
<p>(a and b) IHC showing spindle shaped tumor cells positive for smooth muscle actin and Vimentin and negative for synaptophysin-100, cluster of differentiation 34 and desmin.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g007.tif"/>
</fig>
<p>Surgical excision was further carried out. The patient underwent surgical removal of first metatarsal proximal to tumor along with fibular grafting. The specimen was a greyish-white hard mass measuring 3.3 &#x00D7; 1.5 &#x00D7; 2 cm. There was no particular breach. Diagnosis of LGMFS was confirmed on the excised specimen.</p>
<p>The patient was discharged and was advised to come for follow-up after 6 months. The patient was also advised to come to the hospital earlier in case of any increased pain or fever. Follow-up CT post 6 months of surgical resection demonstrated no recurrence or metastases.</p>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>Discussion</title>
<p>Low-grade fibromyxoid sarcomas are malignant fibroblastic soft-tissue tumors with fibrous and myxoid elements. Another term for the same is Evans tumor. Their incidence is underestimated as they mimic other soft-tissue tumors; however, they are relatively rare.</p>
<p>LGMFS is seen in a wide age range but occur mostly in young adults and adolescents. Men are more commonly affected than female [<xref ref-type="bibr" rid="ref7">7</xref>]. They typically manifest as a painless slow-growing mass. LGMFS commonly arise from the subfascial soft tissues of proximal extremities. In pediatric age group, superficial soft-tissues of the head-and-neck are commonly involved [<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>].</p>
<p>Bone invasion by a primary tumor is rarely reported [<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>]. Surgery is the mainstay of treatment; however, local recurrence is common as seen in almost 50&#x0025; of the cases [<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref13">13</xref>]. There is direct association with grade of tumor and rate of local recurrence, which implies higher the grade, more the risk of metastases [<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>].</p>
<p>Although myxofibrosarcoma is known to metastasize to the bone [<xref ref-type="bibr" rid="ref12">12</xref>], the incidence of primary osseous myxofibrosarcoma is rare, with only a few cases reported in the literature. In 1988, Frassica et al. published the first case of primary osseous myxofibrosarcoma. The case was of a tumor arising in the left distal femur in a middle-aged male [<xref ref-type="bibr" rid="ref15">15</xref>]. Later, in 1997 and 2002, two more cases of myxoid malignant fibrous histiocytoma of the skull were described [<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>]. Romeo et al. in 2012 re-evaluated previously diagnosed &#x201C;malignant fibrous histiocytoma&#x201D; or &#x201C;fibrosarcoma&#x201D; of bone, and three of them were reclassified as myxofibrosarcoma of bone [<xref ref-type="bibr" rid="ref18">18</xref>].</p>
<p>Enchondromas aka chondromas [<xref ref-type="bibr" rid="ref19">19</xref>] are common intramedullary cartilage tumors with benign imaging features. They are commonly detected in pediatric age group and young adults. Enchondromas are the most common benign primary bone neoplasms of extremities (hands/feet) and are commonly seen as well-circumscribed lobulated masses with sharp borders [<xref ref-type="bibr" rid="ref20">20</xref>]. On MR imaging, these shows T2 hyperintense signal with internal foci of low signal of &#x201C;rings and arcs&#x201D;, suggestive of chondroid matrix.</p>
<p>Both LGMFS and enchondromas show hyperintensity on T2 weighted fat saturated images and can be associated with pathological fractures. However, LGMFS is heterogeneous on T2W images with varying amounts of myxoid and fibrous components. (Myxoid component being hyperintense and fibrous component being hypointense on T2W images) [<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref22">22</xref>]. Radiologically, LGMFS mimics a chondroid lesion; however, few pointers which would help to differentiate the two and are preferentially seen in LGMFS &#x2013; (1) Heterogeneous signal on T2W images (few areas being hypointense due to fibrous element), (2) low apparent diffusion coefficient (ADC) values, and (3) slow progressive enhancement. Thus, every lesion which is lobulated having endosteal scalloping and is hyperintense on T2W images should not be thought of as only a chondral lesion [<xref ref-type="bibr" rid="ref23">23</xref>].</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>Conclusion</title>
<p>LGMFS radiologically mimics enchondromas. Both show T2W hyperintensity and can be associated with pathological fractures. MRI features that distinguish LGMFS from enchondroma include low ADC values and slow progressive enhancement in DCEMRI. With every recurrence, LGMFS is associated with increased risk of metastasis; hence, the importance of differentiation between the them.</p>
<boxed-text>
<title>Clinical Message</title>
<p>Every lesion which is lobulated having endosteal scalloping and is hyperintense on T2W images should not be thought of only as a chondral lesion. LGMFS radiologically mimic enchondromas; however, MRI features that distinguish LGMFS from enchondroma include low ADC values and slow progressive enhancement in DCEMRI. LGMFS is known to recur and every recurrence is associated with increased risk of metastasis, hence, the importance of this case report.</p>
</boxed-text>
<p><bold>Declaration of patient consent :</bold> The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given the consent for his/ her images and other clinical information to be reported in the journal. The patient understands that his/ her names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.</p>
<p><bold>Conflict of interest:</bold>Nil <bold>Source of support:</bold>None</p>
</sec>
</body>
<back>
<bio>
<p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g008.tif"/></p>
<p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g009.tif"/></p>
<p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g010.tif"/></p>
<p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JOCR-12-35-g011.tif"/></p>
</bio>
<ref-list>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurisaki-Arakawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Suehara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mitani</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature</article-title>
<source>Diagn Pathol</source>
<year>2014</year>
<volume>9</volume>
<fpage>163</fpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doyle</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>M&#246;ller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cin</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hornick</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma</article-title>
<source>Am J Surg Pathol</source>
<year>2011</year>
<volume>35</volume>
<fpage>733</fpage>
<lpage>41</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maretty-Nielsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baerentzen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dyrop</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Safwat</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Low-grade fibromyxoid sarcoma: Incidence, treatment strategy of metastases, and clinical significance of the FUS gene</article-title>
<source>Sarcoma</source>
<year>2013</year>
<volume>2013</volume>
<fpage>256280</fpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finos</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Righi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frisoni</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gambarotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghinelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benini</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature</article-title>
<source>Pathol Res Pract</source>
<year>2017</year>
<volume>213</volume>
<fpage>461</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Slipak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ercolano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>BT</given-names>
</name>
</person-group>
<article-title>Primary osseous low-grade myxofibrosarcoma of clavicle presenting with multiple skeletal metastases</article-title>
<source>Cureus</source>
<year>2020</year>
<volume>12</volume>
<fpage>e10170</fpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuchie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Emori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murahashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mizushima</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Distant metastasis in patients with myxofibrosarcoma</article-title>
<source>Ups J Med Sci</source>
<year>2017</year>
<volume>122</volume>
<fpage>190</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DQ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Low-grade myofibroblastic sarcoma: Clinical and imaging findings</article-title>
<source>BMC Med Imaging</source>
<year>2019</year>
<volume>19</volume>
<fpage>36</fpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sargar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Spunt</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Parham</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Coffin</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>MRI and CT of low-grade fibromyxoid sarcoma in children: A report from children&#x0027;s oncology group study ARST0332</article-title>
<source>AJR Am J Roentgenol</source>
<year>2015</year>
<volume>205</volume>
<fpage>414</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Low-grade myxofibrosarcoma following a metal implantation in femur: A case report</article-title>
<source>Diagn Pathol</source>
<year>2014</year>
<volume>9</volume>
<fpage>6</fpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>YH</given-names>
</name>
</person-group>
<article-title>Malignant fibrous histiocytoma of the head and neck: CT and MR imaging findings</article-title>
<source>AJNR Am J Neuroradiol</source>
<year>2009</year>
<volume>30</volume>
<fpage>71</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphey</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>HG</given-names>
</name>
</person-group>
<article-title>From the archives of the AFIP. musculoskeletal malignant fibrous histiocytoma: Radiologic-pathologic correlation</article-title>
<source>Radiographics</source>
<year>1994</year>
<volume>14</volume>
<fpage>807</fpage>
<lpage>26</lpage>
<comment>quiz 827-8</comment>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>VY</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>WHO classification of soft tissue tumours: An update based on the 2013 (4th) edition</article-title>
<source>Pathology</source>
<year>2014</year>
<volume>46</volume>
<fpage>95</fpage>
<lpage>104</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mentzel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Calonje</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wadden</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Camplejohn</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Beham</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group>
<article-title>Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant</article-title>
<source>Am J Surg Pathol</source>
<year>1996</year>
<volume>20</volume>
<fpage>391</fpage>
<lpage>405</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kayser</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bruner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chapin</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>Myxofibrosarcoma: First report of myxofibrosarcoma of bone arising at a bone infarct</article-title>
<source>Skeletal Radiol</source>
<year>2017</year>
<volume>46</volume>
<fpage>1143</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frassica</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Case report 462: Grade 2 myxoid fibrosarcoma of femur</article-title>
<source>Skeletal Radiol</source>
<year>1988</year>
<volume>17</volume>
<fpage>77</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakayama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nemoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mochizuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>SB</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Ohata</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Malignant fibrous histiocytoma of the temporal bone with endocranial extension</article-title>
<source>AJNR Am J Neuroradiol</source>
<year>1997</year>
<volume>18</volume>
<fpage>331</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodhams</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Iwabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sagiuchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>A case of malignant fibrous histiocytoma (MFH) in the skull bone presenting extensive permeative osteolysis</article-title>
<source>Radiat Med</source>
<year>2002</year>
<volume>20</volume>
<fpage>141</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romeo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bovee</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Kroon</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Tirabosco</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zanatta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Malignant fibrous histiocytoma and fibrosarcoma of bone: A reassessment in the light of currently employed morphological, immunohistochemical and molecular approaches</article-title>
<source>Virchows Arch</source>
<year>2012</year>
<volume>461</volume>
<fpage>561</fpage>
<lpage>70</lpage>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saifuddin</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The imaging of cartilaginous bone tumours. I. Benign lesions</article-title>
<source>Skeletal Radiol</source>
<year>2012</year>
<volume>41</volume>
<fpage>1195</fpage>
<lpage>212</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walden</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Murphey</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Incidental enchondromas of the knee</article-title>
<source>AJR Am J Roentgenol</source>
<year>2008</year>
<volume>190</volume>
<fpage>1611</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref>
<ref id="ref21">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>MRI findings of low-grade fibromyxoid sarcoma: A case report and literature review</article-title>
<source>BMC Musculoskelet Disord</source>
<year>2018</year>
<volume>19</volume>
<fpage>65</fpage>
</nlm-citation>
</ref>
<ref id="ref22">
<label>22</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petscavage-Thomas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Logie</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Duryea</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Murphey</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Soft-tissue myxomatous lesions: Review of salient imaging features with pathologic comparison</article-title>
<source>Radiographics</source>
<year>2014</year>
<volume>34</volume>
<fpage>964</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref23">
<label>23</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonescu</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Argani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Erlandson</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Healey</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ladanyi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huvos</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>Skeletal and extraskeletal myxoid chondrosarcoma: A comparative clinicopathologic, ultrastructural, and molecular study</article-title>
<source>Cancer</source>
<year>1998</year>
<volume>83</volume>
<fpage>1504</fpage>
<lpage>21</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> Nil</p>
</fn>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="other">
<p><bold>Consent:</bold> The authors confirm that informed consent was obtained from the patient for publication of this case report</p>
</fn>
</fn-group>
</back>
</article>
